While Ozempic is a popular brand of GLP-1 receptor agonist used for weight loss and diabetes management, GLP-1 itself refers to a class of medications with similar effects
A retrospective US FDA Adverse Event Reporting System (FAERS) analysis from January 2013 to June 2020 reported 18,675 unique AEs associated with anti-obesity medications involving 15,143 patients
Our experienced medical team will guide you through any transition between semaglutide products, monitoring your progress, adjusting doses as needed, and ensuring your safety and optimal results
Common side effects include increased appetite (from the higher metabolism) and potential sleep issues if taken too late in the day
By improving how your body responds to insulin, GLP-1 support can reduce the elevated insulin levels that drive many PCOS symptoms
Statistical analyses were performed using a one-way analysis of variance with the TukeyKramer post hoc test and Students or Welchs t-test